Remove FDA Approval Remove Pharmacokinetics Remove Research Laboratories
article thumbnail

New Data Show Treatment with Lilly’s Neutralizing Antibodies Bamlanivimab (LY-CoV555) and Etesevimab (LY-CoV016) Together Reduced Risk of COVID-19 Hospitalizations and Death by 70 Percent

The Pharma Data

Lilly’s chief scientific officer and president of Lilly Research Laboratories. volunteers to evaluate the safety, tolerability, pharmacokinetics and immunogenicity. Bamlanivimab FDA Approval History. have reached record highs. Securities and Exchange Commission. SOURCE Eli Lilly and Company. Source link.

article thumbnail

Retevmo® (selpercatinib) in Advanced RET Fusion-Positive Gastrointestinal and Other Cancers at 2021 American Association for Cancer Research (AACR) Annual Meeting

The Pharma Data

FDA-approved oral prescription medicine, 120 mg or 160 mg dependent on weight (<50 kg or ?50 i Continued approval may be contingent upon verification and description of clinical benefit in confirmatory trials. Retevmo may affect both tumor cells and healthy cells, which can result in side effects. Retevmo is an U.S.

article thumbnail

Codon Digest: Injected Gene Editors

Codon

A giant dataset about the rat brain, and how neurons connect to each other, was collected and pooled together from 20 different research laboratories. Nature Neuroscience. Read You love to see it! Whole-brain mapping of effective connectivity by fMRI with cortex-wide patterned optogenetics. Ricciardi M.J. Press release. Press release.

DNA 52